Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the breast (HP:0000769)help
Parent Node:
expand
Abnormal breast morphology (HP:0031093)help
..Starting node
..expand
Gynecomastia (HP:0000771)help
Term ID: 771
Name: Gynecomastia
Synonym: Enlarged male breast; Gynaecomastia
Definition: Abnormal development of large mammary glands in males resulting in breast enlargement.
Comments:
Reference: HP:0000771
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal nipple morphology (HP:0004404) help
..expandAplasia/Hypoplasia of the breasts (HP:0010311) help
..expandAsymmetry of the breasts (HP:0010312) help
..expandBreast hypertrophy (HP:0010313) help
..expandHypoplastic areola (HP:0100853) help
..expandNeoplasm of the breast (HP:0100013) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000771HP:0000771Gynecomastia0AFF4 CL E G H2712517869ORPHA:444077Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndromeHP:0040283 - Occasional6
HP:0000771HP:0000771Gynecomastia0AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040282 - Frequent95
HP:0000771HP:0000771Gynecomastia0AKT1 CL E G H207391ORPHA:201Cowden syndromeHP:0040283 - Occasional54
HP:0000771HP:0000771Gynecomastia0AKT1 CL E G H207391OMIM:615109Cowden syndrome 6.54
HP:0000771HP:0000771Gynecomastia0AKT2 CL E G H208392ORPHA:293964Hypoinsulinemic hypoglycemia and body hemihypertrophyHP:0040281 - Very frequent12
HP:0000771HP:0000771Gynecomastia0AKT2 CL E G H208392OMIM:240900Hypoinsulinemic hypoglycemia with hemihypertrophy.12
HP:0000771HP:0000771Gynecomastia0ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040283 - Occasional404
HP:0000771HP:0000771Gynecomastia0ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0000771HP:0000771Gynecomastia0ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia.65
HP:0000771HP:0000771Gynecomastia0ANOS1 CL E G H37306211ORPHA:478Kallmann syndromeHP:0040283 - Occasional65
HP:0000771HP:0000771Gynecomastia0AR CL E G H367644OMIM:300068Androgen insensitivity syndrome.125
HP:0000771HP:0000771Gynecomastia0AR CL E G H367644ORPHA:481Kennedy diseaseHP:0040281 - Very frequent125
HP:0000771HP:0000771Gynecomastia0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040282 - Frequent125
HP:0000771HP:0000771Gynecomastia0AR CL E G H367644OMIM:312300Reifenstein syndrome125
HP:0000771HP:0000771Gynecomastia0AR CL E G H367644OMIM:313200Spinal and bulbar muscular atrophy, X-linked 1.125
HP:0000771HP:0000771Gynecomastia0AXL CL E G H558905OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.
HP:0000771HP:0000771Gynecomastia0BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040283 - Occasional
HP:0000771HP:0000771Gynecomastia0CCDC141 CL E G H28502526821OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.
HP:0000771HP:0000771Gynecomastia0CCDC141 CL E G H28502526821ORPHA:478Kallmann syndromeHP:0040283 - Occasional
HP:0000771HP:0000771Gynecomastia0CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040282 - Frequent636
HP:0000771HP:0000771Gynecomastia0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0000771HP:0000771Gynecomastia0CHD7 CL E G H5563620626ORPHA:478Kallmann syndromeHP:0040283 - Occasional515
HP:0000771HP:0000771Gynecomastia0CHD7 CL E G H5563620626ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent515
HP:0000771HP:0000771Gynecomastia0COQ8A CL E G H5699716812ORPHA:139485Autosomal recessive ataxia due to ubiquinone deficiencyHP:0040284 - Very rare136
HP:0000771HP:0000771Gynecomastia0CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0000771HP:0000771Gynecomastia0CUL4B CL E G H84502555OMIM:300354Mental retardation, X-linked, syndromic, Cabezas type38
HP:0000771HP:0000771Gynecomastia0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040283 - Occasional2
HP:0000771HP:0000771Gynecomastia0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0000771HP:0000771Gynecomastia0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0000771HP:0000771Gynecomastia0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040283 - Occasional112
HP:0000771HP:0000771Gynecomastia0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040283 - Occasional53
HP:0000771HP:0000771Gynecomastia0CYP17A1 CL E G H15862593OMIM:202110Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency.53
HP:0000771HP:0000771Gynecomastia0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0000771HP:0000771Gynecomastia0CYP19A1 CL E G H15882594OMIM:139300Aromatase excess syndrome.60
HP:0000771HP:0000771Gynecomastia0CYP21A2 CL E G H15892600OMIM:201910Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency.HP:0003581 - Adult onset86
HP:0000771HP:0000771Gynecomastia0DCC CL E G H16302701ORPHA:478Kallmann syndromeHP:0040283 - Occasional36
HP:0000771HP:0000771Gynecomastia0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0000771HP:0000771Gynecomastia0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0000771HP:0000771Gynecomastia0DUSP6 CL E G H18483072OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.4
HP:0000771HP:0000771Gynecomastia0DUSP6 CL E G H18483072ORPHA:478Kallmann syndromeHP:0040283 - Occasional4
HP:0000771HP:0000771Gynecomastia0DUSP6 CL E G H18483072ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent4
HP:0000771HP:0000771Gynecomastia0ERMARD CL E G H5578021056ORPHA:758576q terminal deletion syndromeHP:0040283 - Occasional36
HP:0000771HP:0000771Gynecomastia0FEZF1 CL E G H38954922788OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.2
HP:0000771HP:0000771Gynecomastia0FEZF1 CL E G H38954922788ORPHA:478Kallmann syndromeHP:0040283 - Occasional2
HP:0000771HP:0000771Gynecomastia0FGF17 CL E G H88223673OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.3
HP:0000771HP:0000771Gynecomastia0FGF17 CL E G H88223673ORPHA:478Kallmann syndromeHP:0040283 - Occasional3
HP:0000771HP:0000771Gynecomastia0FGF17 CL E G H88223673ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent3
HP:0000771HP:0000771Gynecomastia0FGF8 CL E G H22533686ORPHA:478Kallmann syndromeHP:0040283 - Occasional17
HP:0000771HP:0000771Gynecomastia0FGF8 CL E G H22533686ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent17
HP:0000771HP:0000771Gynecomastia0FGFR1 CL E G H22603688OMIM:147950Hypogonadotropic hypogonadism 2 with or without anosmia.172
HP:0000771HP:0000771Gynecomastia0FGFR1 CL E G H22603688ORPHA:478Kallmann syndromeHP:0040283 - Occasional172
HP:0000771HP:0000771Gynecomastia0FGFR1 CL E G H22603688ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent172
HP:0000771HP:0000771Gynecomastia0FLRT3 CL E G H237673762ORPHA:478Kallmann syndromeHP:0040283 - Occasional4
HP:0000771HP:0000771Gynecomastia0FMR1 CL E G H23323775ORPHA:261483Xq27.3q28 duplication syndromeHP:0040282 - Frequent30
HP:0000771HP:0000771Gynecomastia0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0000771HP:0000771Gynecomastia0GNRH1 CL E G H27964419OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.15
HP:0000771HP:0000771Gynecomastia0GNRH1 CL E G H27964419ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent15
HP:0000771HP:0000771Gynecomastia0GNRHR CL E G H27984421OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.92
HP:0000771HP:0000771Gynecomastia0GNRHR CL E G H27984421ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent92
HP:0000771HP:0000771Gynecomastia0HDAC8 CL E G H5586913315ORPHA:3459Wilson-Turner syndromeHP:0040281 - Very frequent37
HP:0000771HP:0000771Gynecomastia0HESX1 CL E G H88204877ORPHA:478Kallmann syndromeHP:0040283 - Occasional21
HP:0000771HP:0000771Gynecomastia0HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040283 - Occasional38
HP:0000771HP:0000771Gynecomastia0HPGD CL E G H32485154ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional55
HP:0000771HP:0000771Gynecomastia0HS6ST1 CL E G H93945201ORPHA:478Kallmann syndromeHP:0040283 - Occasional8
HP:0000771HP:0000771Gynecomastia0HS6ST1 CL E G H93945201ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent8
HP:0000771HP:0000771Gynecomastia0HSD17B3 CL E G H32935212ORPHA:75246,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiencyHP:0040281 - Very frequent31
HP:0000771HP:0000771Gynecomastia0HSD17B3 CL E G H32935212OMIM:264300Pseudohermaphroditism, male, with gynecomastia.31
HP:0000771HP:0000771Gynecomastia0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0000771HP:0000771Gynecomastia0IL17RD CL E G H5475617616ORPHA:478Kallmann syndromeHP:0040283 - Occasional9
HP:0000771HP:0000771Gynecomastia0ITGA3 CL E G H36756139OMIM:614748Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital.6
HP:0000771HP:0000771Gynecomastia0KISS1 CL E G H38146341ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent3
HP:0000771HP:0000771Gynecomastia0KISS1R CL E G H846344510OMIM:614837Hypogonadotropic hypogonadism 8 with or without anosmia.14
HP:0000771HP:0000771Gynecomastia0KISS1R CL E G H846344510ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent14
HP:0000771HP:0000771Gynecomastia0KLLN CL E G H10014474837212ORPHA:201Cowden syndromeHP:0040283 - Occasional1
HP:0000771HP:0000771Gynecomastia0LAS1L CL E G H8188725726ORPHA:3459Wilson-Turner syndromeHP:0040281 - Very frequent8
HP:0000771HP:0000771Gynecomastia0LAS1L CL E G H8188725726OMIM:309585WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS8
HP:0000771HP:0000771Gynecomastia0LEP CL E G H39526553OMIM:614962Leptin deficiency or dysfunction.47
HP:0000771HP:0000771Gynecomastia0LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiencyHP:0040281 - Very frequent47
HP:0000771HP:0000771Gynecomastia0LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiencyHP:0040281 - Very frequent46
HP:0000771HP:0000771Gynecomastia0LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia.9
HP:0000771HP:0000771Gynecomastia0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0000771HP:0000771Gynecomastia0MECP2 CL E G H42046990OMIM:300055Mental retardation, X-linked, syndromic 13950
HP:0000771HP:0000771Gynecomastia0MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040282 - Frequent462
HP:0000771HP:0000771Gynecomastia0NDNF CL E G H7962526256ORPHA:478Kallmann syndromeHP:0040283 - Occasional
HP:0000771HP:0000771Gynecomastia0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0000771HP:0000771Gynecomastia0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0000771HP:0000771Gynecomastia0NSMF CL E G H2601229843OMIM:614838Hypogonadotropic hypogonadism 9 with or without anosmia.6
HP:0000771HP:0000771Gynecomastia0NSMF CL E G H2601229843ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent6
HP:0000771HP:0000771Gynecomastia0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0000771HP:0000771Gynecomastia0PHF6 CL E G H8429518145OMIM:301900Borjeson-Forssman-Lehmann syndrome.29
HP:0000771HP:0000771Gynecomastia0PHF6 CL E G H8429518145ORPHA:127Borjeson-Forssman-Lehmann syndromeHP:0040281 - Very frequent29
HP:0000771HP:0000771Gynecomastia0PIK3CA CL E G H52908975ORPHA:201Cowden syndromeHP:0040283 - Occasional162
HP:0000771HP:0000771Gynecomastia0PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5.162
HP:0000771HP:0000771Gynecomastia0PNPLA6 CL E G H1090816268ORPHA:1173Cerebellar ataxia-hypogonadism syndromeHP:0040281 - Very frequent103
HP:0000771HP:0000771Gynecomastia0POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome.138
HP:0000771HP:0000771Gynecomastia0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040283 - Occasional138
HP:0000771HP:0000771Gynecomastia0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0000771HP:0000771Gynecomastia0PROK2 CL E G H6067518455ORPHA:478Kallmann syndromeHP:0040283 - Occasional9
HP:0000771HP:0000771Gynecomastia0PROK2 CL E G H6067518455ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent9
HP:0000771HP:0000771Gynecomastia0PROKR2 CL E G H12867415836ORPHA:478Kallmann syndromeHP:0040283 - Occasional34
HP:0000771HP:0000771Gynecomastia0PROKR2 CL E G H12867415836ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent34
HP:0000771HP:0000771Gynecomastia0PSMB8 CL E G H56969545OMIM:256040Proteasome-associated autoinflammatory syndrome 1 and digenic forms20
HP:0000771HP:0000771Gynecomastia0PTEN CL E G H57289588ORPHA:201Cowden syndromeHP:0040283 - Occasional948
HP:0000771HP:0000771Gynecomastia0PTEN CL E G H57289588OMIM:158350Cowden syndrome 1.948
HP:0000771HP:0000771Gynecomastia0RBM28 CL E G H5513121863OMIM:612079Alopecia, neurologic defects, and endocrinopathy syndrome.1
HP:0000771HP:0000771Gynecomastia0RBM28 CL E G H5513121863ORPHA:157954ANE syndromeHP:0040282 - Frequent1
HP:0000771HP:0000771Gynecomastia0RNF216 CL E G H5447621698ORPHA:1173Cerebellar ataxia-hypogonadism syndromeHP:0040281 - Very frequent10
HP:0000771HP:0000771Gynecomastia0RSPO1 CL E G H28465421679OMIM:610644Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46,xx sex reversal.3
HP:0000771HP:0000771Gynecomastia0SDHB CL E G H639010681ORPHA:201Cowden syndromeHP:0040283 - Occasional237
HP:0000771HP:0000771Gynecomastia0SDHC CL E G H639110682ORPHA:201Cowden syndromeHP:0040283 - Occasional147
HP:0000771HP:0000771Gynecomastia0SDHD CL E G H639210683ORPHA:201Cowden syndromeHP:0040283 - Occasional129
HP:0000771HP:0000771Gynecomastia0SEC23B CL E G H1048310702ORPHA:201Cowden syndromeHP:0040283 - Occasional60
HP:0000771HP:0000771Gynecomastia0SEMA3A CL E G H1037110723ORPHA:478Kallmann syndromeHP:0040283 - Occasional14
HP:0000771HP:0000771Gynecomastia0SEMA3E CL E G H972310727OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.16
HP:0000771HP:0000771Gynecomastia0SH3PXD2B CL E G H28559029242ORPHA:137834Frank-Ter Haar syndromeHP:0040283 - Occasional134
HP:0000771HP:0000771Gynecomastia0SLC29A3 CL E G H5531523096ORPHA:168569H syndromeHP:0040283 - Occasional68
HP:0000771HP:0000771Gynecomastia0SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0000771HP:0000771Gynecomastia0SLCO2A1 CL E G H657810955ORPHA:2796PachydermoperiostosisHP:0040283 - Occasional13
HP:0000771HP:0000771Gynecomastia0SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeHP:0040282 - Frequent174
HP:0000771HP:0000771Gynecomastia0SOX10 CL E G H666311190ORPHA:478Kallmann syndromeHP:0040283 - Occasional61
HP:0000771HP:0000771Gynecomastia0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0000771HP:0000771Gynecomastia0SPRY4 CL E G H8184815533OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.5
HP:0000771HP:0000771Gynecomastia0SPRY4 CL E G H8184815533ORPHA:478Kallmann syndromeHP:0040283 - Occasional5
HP:0000771HP:0000771Gynecomastia0SPRY4 CL E G H8184815533ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent5
HP:0000771HP:0000771Gynecomastia0SPTBN1 CL E G H671111275OMIM:619475DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
HP:0000771HP:0000771Gynecomastia0SRA1 CL E G H1001111281OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.
HP:0000771HP:0000771Gynecomastia0SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesisHP:0040283 - Occasional23
HP:0000771HP:0000771Gynecomastia0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0000771HP:0000771Gynecomastia0SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0000771HP:0000771Gynecomastia0STK11 CL E G H679411389OMIM:175200Peutz-Jeghers syndrome.740
HP:0000771HP:0000771Gynecomastia0TAC3 CL E G H686611521ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent6
HP:0000771HP:0000771Gynecomastia0TACR3 CL E G H687011528ORPHA:478Kallmann syndromeHP:0040283 - Occasional34
HP:0000771HP:0000771Gynecomastia0TACR3 CL E G H687011528ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent34
HP:0000771HP:0000771Gynecomastia0TCF20 CL E G H694211631OMIM:618430Developmental delay with variable intellectual impairment and behavioral abnormalities1
HP:0000771HP:0000771Gynecomastia0TMEM53 CL E G H7963926186OMIM:619727CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE; CTDI
HP:0000771HP:0000771Gynecomastia0USF3 CL E G H20571730494ORPHA:201Cowden syndromeHP:0040283 - Occasional1
HP:0000771HP:0000771Gynecomastia0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0000771HP:0000771Gynecomastia0WDR11 CL E G H5571713831OMIM:146110Hypogonadotropic hypogonadism 7 without anosmia.10
HP:0000771HP:0000771Gynecomastia0WDR11 CL E G H5571713831ORPHA:478Kallmann syndromeHP:0040283 - Occasional10
HP:0000771HP:0000771Gynecomastia0WDR11 CL E G H5571713831ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040282 - Frequent10
HP:0000771HP:0000771Gynecomastia0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0000771HP:0000771Gynecomastia0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0000771HP:0000771Gynecomastia0ZBTB20 CL E G H2613713503ORPHA:3042Intellectual disability-cataracts-calcified pinnae-myopathy syndromeHP:0040282 - Frequent17
HP:0000771HP:0000771Gynecomastia0ZBTB20 CL E G H2613713503OMIM:259050Primrose syndrome.17
HP:0000771HP:0000771Gynecomastia0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31


Genes (99) :AFF4 AIP AKT1 AKT2 ALMS1 ANOS1 AR AXL BMP6 CCDC141 CDH23 CHD7 COQ8A CPE CUL4B CYB5A CYP11A1 CYP11B1 CYP17A1 CYP19A1 CYP21A2 DCC DHX37 DMRT3 DUSP6 ERMARD FEZF1 FGF17 FGF8 FGFR1 FLRT3 FMR1 GATA4 GNRH1 GNRHR HDAC8 HESX1 HFE HPGD HS6ST1 HSD17B3 HSD3B2 IL17RD ITGA3 KISS1 KISS1R KLLN LAS1L LEP LEPR LHB MAP3K1 MECP2 MEN1 NDNF NR0B1 NR5A1 NSMF PDE11A PHF6 PIK3CA PNPLA6 POLR3A PRKAR1A PROK2 PROKR2 PSMB8 PTEN RBM28 RNF216 RSPO1 SDHB SDHC SDHD SEC23B SEMA3A SEMA3E SH3PXD2B SLC29A3 SLCO2A1 SMCHD1 SOX10 SOX9 SPRY4 SPTBN1 SRA1 SRY STK11 TAC3 TACR3 TCF20 TMEM53 USF3 VAMP7 WDR11 WT1 WWOX ZBTB20 ZFPM2

Diseases (72) :ORPHA:444077 ORPHA:2965 ORPHA:201 OMIM:615109 ORPHA:293964 OMIM:240900 ORPHA:64 OMIM:203800 OMIM:308700 ORPHA:478 OMIM:300068 ORPHA:481 ORPHA:90797 OMIM:312300 OMIM:313200 OMIM:146110 ORPHA:465508 ORPHA:91347 ORPHA:432 ORPHA:139485 OMIM:619326 OMIM:300354 ORPHA:90796 ORPHA:168558 ORPHA:289548 ORPHA:90795 OMIM:202110 ORPHA:90793 OMIM:139300 OMIM:201910 ORPHA:251510 ORPHA:75857 OMIM:147950 ORPHA:261483 ORPHA:3459 ORPHA:2796 ORPHA:752 OMIM:264300 ORPHA:90791 OMIM:614748 OMIM:614837 OMIM:309585 OMIM:614962 ORPHA:66628 ORPHA:179494 OMIM:228300 OMIM:300055 OMIM:614838 ORPHA:1359 OMIM:301900 ORPHA:127 OMIM:615108 ORPHA:1173 OMIM:264090 ORPHA:3455 OMIM:256040 OMIM:158350 OMIM:612079 ORPHA:157954 OMIM:610644 ORPHA:137834 ORPHA:168569 OMIM:602782 ORPHA:2250 OMIM:619475 ORPHA:1772 OMIM:400045 OMIM:175200 OMIM:618430 OMIM:619727 ORPHA:3042 OMIM:259050
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.